Pivotal Response Treatment for School-Aged Children and Adolescents with Autism Spectrum Disorder: A Randomized Controlled Trial

J Autism Dev Disord. 2021 Dec;51(12):4506-4519. doi: 10.1007/s10803-021-04886-0. Epub 2021 Feb 9.

Abstract

Pivotal Response Treatment (PRT) is promising for children with Autism Spectrum Disorder (ASD), but more methodologically robust designed studies are needed. In this randomized controlled trial, forty-four children with ASD, aged 9-15 years, were randomly allocated to PRT (n = 22) or treatment-as-usual (TAU; n = 22). Measurements were obtained after 12- and 20-weeks treatment, and 2-month follow-up. PRT resulted in significant greater improvements on parent-rated social-communicative skills after 12 weeks treatment (p = .004, partial η2 = 0.22), compared to TAU. Furthermore, larger gains in PRT compared to TAU were observed on blindly rated global functioning, and parent-rated adaptive socialization skills and attention problems. Implications for clinical practice and suggestions for future research are discussed.

Keywords: Adolescents; Autism spectrum disorder (ASD); Pivotal response treatment (PRT); Randomized controlled trial; School-age.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Autism Spectrum Disorder* / therapy
  • Child
  • Communication
  • Humans
  • Parents
  • Schools
  • Social Skills